Elizabeth Norton

1.8k total citations
27 papers, 1.4k citations indexed

About

Elizabeth Norton is a scholar working on Epidemiology, Virology and Pharmacy. According to data from OpenAlex, Elizabeth Norton has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Virology and 5 papers in Pharmacy. Recurrent topics in Elizabeth Norton's work include Herpesvirus Infections and Treatments (6 papers), Poxvirus research and outbreaks (6 papers) and Virus-based gene therapy research (5 papers). Elizabeth Norton is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Poxvirus research and outbreaks (6 papers) and Virus-based gene therapy research (5 papers). Elizabeth Norton collaborates with scholars based in United States, France and Canada. Elizabeth Norton's co-authors include Enzo Paoletti, Marion E. Perkus, Stephen W. Davis, Scott J. Goebel, James Tartaglia, Gerard P. Johnson, Jill Taylor, Michel Rivière, B. Languet and William I. Cox and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Elizabeth Norton

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Norton United States 16 682 650 460 286 271 27 1.4k
W. F. Robinson Australia 26 504 0.7× 385 0.6× 539 1.2× 293 1.0× 203 0.7× 73 1.8k
Caroline Leroux France 25 699 1.0× 610 0.9× 432 0.9× 188 0.7× 215 0.8× 65 1.8k
Jean‐François Mornex France 23 640 0.9× 378 0.6× 308 0.7× 288 1.0× 214 0.8× 79 1.8k
David A. Garber United States 25 747 1.1× 593 0.9× 285 0.6× 341 1.2× 530 2.0× 48 1.6k
M Bendinelli Italy 21 1.0k 1.5× 790 1.2× 529 1.1× 203 0.7× 318 1.2× 101 1.7k
Luca Ceccherini‐Nelli Italy 26 1.0k 1.5× 414 0.6× 441 1.0× 336 1.2× 266 1.0× 71 2.2k
Gregg A. Dean United States 29 681 1.0× 729 1.1× 468 1.0× 273 1.0× 586 2.2× 80 1.9k
JoAnn L. Yee United States 23 674 1.0× 701 1.1× 148 0.3× 220 0.8× 296 1.1× 61 1.9k
Sally E. Adams United Kingdom 26 397 0.6× 637 1.0× 155 0.3× 794 2.8× 534 2.0× 53 2.2k
D. Neumann‐Haefelin Germany 29 1.3k 1.9× 668 1.0× 590 1.3× 452 1.6× 373 1.4× 84 2.4k

Countries citing papers authored by Elizabeth Norton

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Norton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Norton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Norton more than expected).

Fields of papers citing papers by Elizabeth Norton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Norton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Norton. The network helps show where Elizabeth Norton may publish in the future.

Co-authorship network of co-authors of Elizabeth Norton

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Norton. A scholar is included among the top collaborators of Elizabeth Norton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Norton. Elizabeth Norton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mingueneau, Michaël, Saida Boudaoud, Scott Haskett, et al.. (2016). Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation. Journal of Allergy and Clinical Immunology. 137(6). 1809–1821.e12. 124 indexed citations
2.
Norton, Elizabeth, et al.. (2014). Operating Room Clinicians’ Attitudes and Perceptions of a Pediatric Surgical Safety Checklist at 1 Institution. Journal of Patient Safety. 12(1). 44–50. 14 indexed citations
3.
Ellis, Laura, Elizabeth Norton, Xin Dang, & Igor J. Koralnik. (2013). Agnogene Deletion in a Novel Pathogenic JC Virus Isolate Impairs VP1 Expression and Virion Production. PLoS ONE. 8(11). e80840–e80840. 17 indexed citations
4.
Wüthrich, Christian, Bogdan F. Gh. Popescu, Sarah Gheuens, et al.. (2013). Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis: A Postmortem Study. Journal of Neuropathology & Experimental Neurology. 72(11). 1043–1051. 15 indexed citations
5.
Norton, Elizabeth, et al.. (2012). A Nurse‐led Approach to Developing and Implementing a Collaborative Count Policy. AORN Journal. 95(2). 222–227. 5 indexed citations
6.
Norton, Elizabeth, et al.. (2011). Patients Count on It: An Initiative to Reduce Incorrect Counts and Prevent Retained Surgical Items. AORN Journal. 95(1). 109–121. 30 indexed citations
7.
Norton, Elizabeth. (2011). Using an Alternative Site Marking Form to Comply With the Universal Protocol. AORN Journal. 93(5). 600–606. 1 indexed citations
8.
Norton, Elizabeth & Shawn J. Rangel. (2010). Implementing a Pediatric Surgical Safety Checklist in the OR and Beyond. AORN Journal. 92(1). 61–71. 38 indexed citations
9.
Knapp, Karen, et al.. (2009). A People to People Nursing Experience in Poland. AORN Journal. 90(3). 435–440.
10.
Knapp, Karen, et al.. (2009). A People to People Nursing Experience in Russia. AORN Journal. 90(1). 109–114. 1 indexed citations
11.
Norton, Elizabeth. (2007). Implementing the Universal Protocol Hospital‐Wide. AORN Journal. 85(6). 1187–1197. 31 indexed citations
12.
Taylor, Jill, James Tartaglia, C. Richardson, et al.. (1992). Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology. 187(1). 321–328. 118 indexed citations
13.
Tartaglia, James, Marion E. Perkus, Elizabeth Norton, et al.. (1992). NYVAC: A highly attenuated strain of vaccinia virus. Virology. 188(1). 217–232. 364 indexed citations
14.
Perkus, Marion E., Scott J. Goebel, Stephen W. Davis, et al.. (1991). Deletion of 55 open reading frames from the termini of vaccinia virus. Virology. 180(1). 406–410. 91 indexed citations
15.
Taylor, Jill, S Pincus, James Tartaglia, et al.. (1991). Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. Journal of Virology. 65(8). 4263–4274. 57 indexed citations
16.
Goebel, Scott J., et al.. (1990). A DNA ligase gene in the copenhagen strain of vaccinia virus is nonessential for viral replication and recombination. Virology. 179(1). 267–275. 45 indexed citations
17.
Taylor, Jill, et al.. (1990). Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. Journal of Virology. 64(4). 1441–1450. 100 indexed citations
18.
Perkus, Marion E., Scott J. Goebel, Stephen W. Davis, et al.. (1990). Vaccinia virus host range genes. Virology. 179(1). 276–286. 160 indexed citations
19.
Laterra, John, Elizabeth Norton, Colin S. Izzard, & Lloyd A. Culp. (1983). Contact formation by fibroblasts adhering to heparan sulfate-binding substrata (fibronectin or platelet factor 4). Experimental Cell Research. 146(1). 15–27. 52 indexed citations
20.
Norton, Elizabeth & Colin S. Izzard. (1982). Fibronectin promotes formation of the close cell-to-substrate contact in cultured cells. Experimental Cell Research. 139(2). 463–467. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026